Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Metabolomics : Official Journal of the Metabolomic Society|May 24, 2017
The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivoMonte S Willis, Amro Ilaiwy, Megan D Montgomery, et al.
Pharmacotherapy|November 22, 2021
Chemotherapy-associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategiesJustin A Veeder, Lauren N Hothem, Amber E Cipriani, et al.
JACC. Case Reports|December 18, 2024
Unmasking Primary Carnitine Deficiency as a Mimic of Hypertrophic CardiomyopathySarah G Stafford, Charlie J Sang, Brian C Jensen, et al.
Heart Failure Reviews|December 20, 2018
Practical guidance on the use of sacubitril/valsartan for heart failureAndrew J Sauer, Robert Cole, Brian C Jensen, et al.
Journal of the American College of Cardiology|September 19, 2009
The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteriesBrian C Jensen, Philip M Swigart, Marie-Eve Laden, et al.
Journal of Leukocyte Biology|February 12, 2025
Multifaceted roles of neutrophils in cardiac diseaseSamantha M Morrissey, Logan G Kirkland, Tasha K Phillips, et al.
Current Oncology Reports|March 15, 2023
Clonal Hematopoiesis and the Heart: a Toxic RelationshipJeffrey L Jensen, Saumya Easaw, Travis Anderson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 26, 2009
Heart failure switches the RV alpha1-adrenergic inotropic response from negative to positiveGuan-Ying Wang, Che-Chung Yeh, Brian C Jensen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 14, 2015
A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapyJason N Katz, Brian C Jensen, Patricia P Chang, et al.
Pageof 9